Related Experiment Video
Updated: Apr 11, 2026

Identifying Coronary Artery Calcification on Non-gated Computed Tomography Scans
Published on: August 28, 2018
Cystatin C Is Not Causally Related to Coronary Artery Disease
Patrik Svensson-Färbom1, Peter Almgren2, Bo Hedblad2
1Trelleborg Hospital, Department of Internal Medicine, Trelleborg, Sweden; Institution of Clinical Sciences, Lund University, Malmö, Sweden.
Insights
Genetic factors influencing plasma cystatin C levels do not appear to causally affect coronary artery disease (CAD) risk. The observed association between cystatin C and CAD is likely explained by its relationship with estimated glomerular filtration rate (eGFR).
Area of Science:
- Cardiovascular disease research
- Genetic epidemiology
- Biomarker analysis
Background:
- Plasma cystatin C is independently associated with cardiovascular disease (CVD) risk.
- This suggests a potential causal role for cystatin C in CVD pathogenesis.
Purpose of the Study:
- To investigate the causal relationship between plasma cystatin C and coronary artery disease (CAD) risk.
- Utilized a Mendelian Randomization approach to assess causality.
Main Methods:
- Estimated the association between plasma cystatin C and CAD risk.
- Assessed the association of a key cystatin C-related single nucleotide polymorphism (SNP), rs13038305, with plasma cystatin C levels.
- Examined the relationship between rs13038305 and CAD risk in population-based cohorts (Malmö Diet and Cancer Study and CARDIOGRAM).
Main Results:
- An increase in plasma cystatin C was associated with a higher risk of CAD (OR = 1.20).
- The SNP rs13038305 strongly predicted higher plasma cystatin C concentrations (P<1 x 10-35).
- However, rs13038305 was not significantly associated with CAD risk in pooled analyses (OR = 1.00, P = 0.83).
Conclusions:
- Genetic predisposition to elevated plasma cystatin C does not alter CAD risk.
- This indicates no direct causal link between plasma cystatin C and CAD.
- The association between cystatin C and CAD is likely mediated by its relationship with estimated glomerular filtration rate (eGFR).
Background:
Strong and independent associations between plasma concentration of cystatin C and risk of cardiovascular disease (CVD) suggests causal involvement of cystatin C.
Aim:
The aim of our study was to assess whether there is a causal relationship between plasma concentration of cystatin C and risk of coronary artery disease (CAD) using a Mendelian Randomization approach.
Methods:
We estimated the strength of association of plasma cystatin C on CAD risk and the strength of association of the strongest GWAS derived cystatin C SNP (rs13038305) on plasma cystatin C in the population-based Malmö Diet and Cancer Study (MDC) and thereafter the association between rs13038305 and CAD in the MDC (3200 cases of CAD and 24418 controls) and CARDIOGRAM (22233 cases of CAD and 64762 controls).
Results:
Each standard deviation (SD) increment of plasma cystatin C was associated with increased risk of CAD (OR = 1.20, 95% CI 1.07-1.34) after full adjustment. Each copy of the major allele of rs13038305 was associated with 0.34 SD higher plasma concentration of cystatin C (P<1 x 10-35), resulting in a power of >98% to detect a significant relationship between rs13038305 and CAD in MDC and CARDIOGRAM pooled. The odds ratio for CAD (per copy of the major rs13038305 allele) was 1.00 (0.94-1.07); P = 0.92 in MDC, 0.99 (0.96-1.03); P = 0.84 in CARDIOGRAM and 1.00 (0.97-1.03); P = 0.83 in MDC and CARDIOGRAM pooled.
Conclusion:
Genetic elevation of plasma cystatin C is not related to altered risk of CAD, suggesting that there is no causal relationship between plasma cystatin C and CAD. Rather, the association between cystatin C and CAD appears to be due to the association of eGFR and CAD.
More Related Videos
Related Concept Videos
Coronary Artery Disease I: Introduction
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Correlation and Causation
Correlation versus Causation
If the dependent variable increases or decreases when the independent variable increases, there is a positive or negative...
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease IV: Preventive Measures

